PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1.

"Declarations Ethics approval and consent to participateAll animal studies were performed following the protocols approved by the Animal Center of the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College (ethical code: ACUC-A01-2022-042). Consent for publicationConsent to publish has been obtained from all authors. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS) (2021-1-I2M-018), Haihe Laboratory of Cell Ecosystem Innovation Fund (22HHXBSS00012), National Natural Science Foundation of China (81730078, 81872287), Beijing Natural Science Foundation (IS23095) and State Key Laboratory Special Fund (2060204)."